Amgen to pay $24.75M in settlement over patient assistance programs
Amgen announced that it has reached a settlement agreement with the federal government to resolve civil claims relating to certain financial donations made by the company to certain independent charity patient assistance foundations prior to 2017. Under the agreement, Amgen will pay $24.75M to the government to resolve these claims. "Amgen is among a number of companies that previously disclosed receiving subpoenas in connection with a government inquiry related to organizations that provide financial assistance to Medicare patients. The conduct covered by Amgen's settlement involves allegations by the government that Amgen's donations to independent charitable organizations that provide patients with financial assistance to access their medicines did not comply with federal law. Amgen does not agree with the government's view of the relevant facts or that its conduct was inappropriate; accordingly, the settlement does not contain or constitute an admission of liability. As part of the settlement, Amgen has also entered into a Corporate Integrity Agreement with the Office of Inspector General of the U.S. Department of Health and Human Services. The Corporate Integrity Agreement sets certain requirements for Amgen, most of which have already been incorporated into our existing compliance program," the company said.